Description

Escuven (aescin) gel 1% 50 g

Ingredients

Active ingredient: Aescin 1%
Other ingredients: Aqua, Carbomer, Triethanolamine, Isopropyl Alcohol.

Dosage

Apply a thin layer of Escuven gel to the affected area 2-3 times daily.
Gently massage the gel into the skin until fully absorbed.
Avoid contact with eyes, mucous membranes, or open wounds.

Indications

Escuven gel is indicated for the relief of symptoms associated with varicose veins, such as pain, swelling, and heaviness in the legs.
It helps to improve blood circulation and reduce inflammation in the affected area.

Contraindications

Do not use Escuven gel if you are allergic to aescin or any other ingredients in the gel.
Consult a healthcare professional before use if pregnant, nursing, or have any medical conditions.

Directions

Clean and dry the affected area before applying Escuven gel.
Gently rub the gel into the skin until absorbed.
Wash hands after application.

Scientific Evidence

Aescin, the active ingredient in Escuven gel, has been extensively studied for its anti-inflammatory and venotonic properties.
Research has shown that aescin helps to strengthen blood vessels, reduce capillary permeability, and improve lymphatic drainage.
Clinical trials have demonstrated the efficacy of aescin in reducing edema and improving symptoms of chronic venous insufficiency.

Additional Information

Escuven gel is a well-tolerated topical treatment for varicose veins and related symptoms.
Regular use as directed can help alleviate discomfort and improve the appearance of varicose veins over time.

Pharmacological Effects: Aescin, the active compound in Escuven gel, acts by stabilizing the walls of blood vessels, reducing inflammation, and promoting circulation. This leads to a decrease in swelling and pain associated with varicose veins.

Clinical Trials: In a randomized controlled trial published in the Journal of Vascular Research, aescin gel was found to significantly reduce leg volume and improve symptoms in patients with chronic venous insufficiency compared to a placebo.